Tumor genome analysis includes germline genome: are we ready for surprises? - Wikidata - awgldk - TriplyDB

Tumor genome analysis includes germline genome: are we ready for surprises?

Tumor genome analysis includes germline genome: are we ready for surprises?

http://www.wikidata.org/entity/Q35004182

about

Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity Clinical tumor sequencing: opportunities and challenges for precision cancer medicine Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?Management of Incidental Findings in the Era of Next-generation Sequencing The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance Next-Generation Sequencing to Guide Clinical Trials.Data resources for the identification and interpretation of actionable mutations by clinicians.Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories Changing paradigm of cancer therapy: precision medicine by next-generation sequencing.Evaluation of chemical mutagenicity using next generation sequencing: A review.Ethical frameworks for obtaining informed consent in tumour profiling: an evidence-based case for Singapore.Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives.Additional germline findings from a tumor profiling program Familial pancreatic cancer Precision oncology: separating the wheat from the chaff

P2860

Q26992272-CE52C104-658C-4DE6-9EF5-CB2BAFDD924E Q27027942-54F6F183-67C2-442C-894D-210A6B7EEBC6 Q30783484-0BAA8EEE-1F91-4A40-86F9-CA98E1C1A847 Q31114379-D49DA89D-006B-4F24-8949-5720BF4E08D2 Q35697689-64B2E233-8CEF-4C60-B8B1-6E61D54DC475 Q36024161-12C38E21-136D-462B-889F-EEA0F9011DDD Q36174832-DBFC9A8E-2873-4779-881C-D173F1102E8C Q36317783-840C1B4E-ECCC-4E8C-99ED-013A2892FE4A Q36847816-AAC5B548-2549-4549-972A-CD7DCF191FC6 Q36849642-E4ACC6B9-CF33-4A88-B816-F28A07CD93D2 Q38785395-F1CB781A-B5B7-4D90-A074-5519E6F49700 Q45951380-58B1145B-2CBD-492E-A3E4-D6278F34C7F4 Q47109110-B33F7364-B10F-4ABF-9CAE-9952D71974A4 Q47566263-5C709405-778D-4FF3-B0ED-BD52CF035F09 Q57640179-622882B3-0F42-4BAF-ABA5-4E500487CDFF Q57643835-3BE8C8ED-C818-4167-996C-101FF5DADACB Q58698377-23020DF4-F7D6-4921-A649-089FB0F208E2

P2860

Tumor genome analysis includes germline genome: are we ready for surprises?

http://www.wikidata.org/entity/Q35004182

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tumor genome analysis includes germline genome: are we ready for surprises?

@ast

Tumor genome analysis includes germline genome: are we ready for surprises?

@en

type

label

Tumor genome analysis includes germline genome: are we ready for surprises?

@ast

Tumor genome analysis includes germline genome: are we ready for surprises?

@en

prefLabel

Tumor genome analysis includes germline genome: are we ready for surprises?

@ast

Tumor genome analysis includes germline genome: are we ready for surprises?

@en

P1433

Q35004182-82B2BF74-6B98-4B0F-85D1-FCE012508F58

P1476

Q35004182-ED3422E7-E4E4-447D-B279-FFBF43F383BC

P2093

Q35004182-05080B5C-0ABC-498B-8B01-F404314F2BB0

Q35004182-1223B613-16DF-4380-94E5-9211CE69C363

Q35004182-301D5DF3-3007-41CD-B1F5-5DE3FC67F090

Q35004182-3E02EE57-5B39-4BE6-AC47-CC09FCE8315E

Q35004182-4F5C5361-CB1C-4672-B7AA-1B3B4E218908

Q35004182-6956EDC4-4D42-4BBE-8595-4F33D1EEDFB8

Q35004182-782559F2-DBC8-4B78-B219-733F249FE652

Q35004182-C8A3C3B2-9539-48E0-8A56-28DED6E00B03

Q35004182-D3B225EC-6CF8-4458-8A56-C751B153B11C

Q35004182-D6A16FD8-D31E-4967-B161-3E585F9DAB13

P2860

Q35004182-00E3AEA0-F6ED-4E84-99B7-475865E34633

Q35004182-01502409-57DA-478C-926C-EC07721CF196

Q35004182-0670349F-EC4E-49FB-A2BF-92E34F3027DC

Q35004182-09AED320-FD30-497D-8907-C6BD490ACFE6

Q35004182-09FC426E-4AF8-4459-B641-E2D88E11AE9B

Q35004182-0F59848D-4E9D-4CEB-9233-61C753116984

Q35004182-177CF561-9896-4B7F-B93E-7089775A9C71

Q35004182-1ABD00A1-FDC7-44EA-A84A-BF91BFC485B1

Q35004182-251197A9-9CB6-4F44-A06E-57A55C823399

Q35004182-3F0CD05C-0A92-4F7C-94C6-CEFAAF4BF4D4

P304

Q35004182-E2FE6CFB-A245-4F37-8EEA-B1EA608496B9

P31

Q35004182-A67DBB75-98C9-4C9B-B3A0-5EF795656FA2

P356

Q35004182-D692248C-905D-4EB6-AD98-209EA746829F

P433

Q35004182-F9576319-7B85-4D0D-9E2E-12E7CC9AF8CA

P478

Q35004182-697CE49F-EC63-48AD-B6C4-EBE9A1073165

P50

Q35004182-89BCF48F-94EA-4654-8794-03615C14CAD6

P577

Q35004182-5EC8B777-8A56-44E6-9FF3-0AFA1A823CBB

P5875

Q35004182-506A14F9-433C-4743-B806-6F53C5C57256

P698

Q35004182-0ED37A90-BB37-4C80-9EAF-E2807EAA6FD1

P932

Q35004182-EA7B2831-301C-4821-B14F-99BC5CFB26E9

P356

P1433

International Journal of Cancer

P1476

Tumor genome analysis includes germline genome: are we ready for surprises?

@en

P2093

Andrea L Amico

http://www.w3.org/2001/XMLSchema#string

Brittany Rambo

http://www.w3.org/2001/XMLSchema#string

Cassandra Gulden

http://www.w3.org/2001/XMLSchema#string

Daniel M Geynisman

http://www.w3.org/2001/XMLSchema#string

Daniel V T Catenacci

http://www.w3.org/2001/XMLSchema#string

George B Carey

http://www.w3.org/2001/XMLSchema#string

Hedy L Kindler

http://www.w3.org/2001/XMLSchema#string

Jim Fackenthal

http://www.w3.org/2001/XMLSchema#string

Robert D Marsh

http://www.w3.org/2001/XMLSchema#string

Sarah M Nielsen

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Clinical analysis and interpretation of cancer genome data

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

The search for unaffected individuals with Lynch syndrome: do the ends justify the means?

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative.

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.

Building a personalized medicine infrastructure at a major cancer center.

Next-generation companion diagnostics: promises, challenges, and solutions.

P304

1559-1567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.29128

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Olufunmilayo Olopade

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264546938

http://www.w3.org/2001/XMLSchema#string

P698

25123297

http://www.w3.org/2001/XMLSchema#string

P932

4303936

http://www.w3.org/2001/XMLSchema#string